First Community Trust’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-325
Closed -$33K 367
2025
Q4
$33K Hold
325
0.02% 208
2025
Q3
$17.8K Hold
325
0.01% 250
2025
Q2
$17.3K Hold
325
0.01% 247
2025
Q1
$14.1K Hold
325
0.01% 248
2024
Q4
$18.3K Hold
325
0.01% 242
2024
Q3
$22.1K Sell
325
-300
-48% -$16.9K 0.02% 222
2024
Q2
$26.4K Hold
625
0.02% 201
2024
Q1
$43.2K Buy
625
+10
+2% +$633 0.04% 162
2023
Q4
$45.5K Hold
615
0.05% 149
2023
Q3
$42K Hold
615
0.05% 156
2023
Q2
$57.7K Hold
615
0.06% 132
2023
Q1
$41.7K Hold
615
0.05% 160
2022
Q4
$30K Hold
615
0.03% 183
2022
Q3
$20K Buy
615
+50
+9% +$2.06K 0.03% 188
2022
Q2
$22K Sell
565
-50
-8% -$2.67K 0.03% 214
2022
Q1
$43K Hold
615
0.04% 179
2021
Q4
$47.9K Buy
+615
New +$54.3K 0.04% 177

Other funds holding EXAS

First Community Trust's EXAS Position: Q1 2026 in Review

First Community Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 325 shares — an estimated $33K sold.

First Community Trust first reported a position in EXAS in Q4 2021 and held it in 17 quarters. The position peaked at $57.7K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • First Community Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • First Community Trust sold 325 Exact Sciences shares in Q1 2026, an estimated $33K.
  • First Community Trust first reported a position in Exact Sciences in Q4 2021 and held it in 17 quarters.
  • First Community Trust's Exact Sciences position peaked at $57.7K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on First Community Trust's 13F filing for Q1 2026, filed 16 Apr 2026.